Navigation Links
Quark Pharmaceuticals and Major Pharmaceutical Company Enter into Licensing Option Agreement for the p53 Suppressor Drug QPI-1002, the First siRNA Administered Systemically in Human
Date:8/18/2010

ent populations and an independent Data Safety Monitoring Board recommended continuation of QPI-1002 clinical development in both diseases. QPI-1002 was granted Orphan designation by the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) for the prophylaxis of delayed graft function in kidney transplant patients.

About Quark Pharmaceuticals, Inc.Quark Pharmaceuticals, Inc., a world leader in novel RNAi discovery and development, has the largest clinical-stage siRNA pipeline in the industry. The Company's fully integrated drug development platform spans therapeutic target identification to drug development.  Quark's approach to delivery allows targeting of tissues and organs including the eye, kidney, ear, lung, spinal cord and brain.

In addition to QPI-1002, Quark's pipeline includes PF-655, currently in two Phase II clinical trials for the treatment of wet age-related macular degeneration (AMD) and diabetic macular edema (DME). The siRNA therapeutic candidate PF-655 is licensed to Pfizer, who is conducting both trials in collaboration with Quark. PF-655 targets Quark's proprietary gene, RTP801, discovered using its BiFAR™ target discovery platform that identifies clinically relevant critical genes and proteins that reverse the disease phenotype when inhibited. The Company owns a family of patents covering the RTP801 gene, its RNA and protein product sequences, specific antibodies, and gene inhibition across different pathologies. For the structure of these products, Quark has obtained licenses from Silence Therapeutics and from Alnylam Pharmaceuticals.

Quark is currently conducting clinical trials of QPI-1007, its proprietary synthetic siRNA drug candidate for ocular neuroprotection. QPI-1007 utilizes a proprietary structure developed in collaboration with BioSpring GmbH that provides Quark with freedom to operate in the siRNA intellectual property arena and chemical modifications that are designed to pr
'/>"/>

SOURCE Quark Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
2. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
3. Quark Pharmaceuticals Files Patent Application Covering Novel Chemical Modifications to its RNAi Molecules
4. Quark Pharmaceuticals Appoints New Chief Medical Officer
5. Quark Pharmaceuticals Signs Collaboration Agreement With University of Michigan for Development of Proprietary SiRNA Compounds for Noise-Induced Hearing Loss
6. Quark Pharmaceuticals, Inc. Announces First Systemic siRNA Dosing in Humans
7. Quark Pharmaceuticals Announces First Patient Dosing by Pfizer in Phase II Trial of RNAi Therapy in Diabetic Macular Edema
8. Silence Therapeutics to Receive $1.9m Milestone Payment as Pfizer and Quark Commence Phase II Trial
9. Quark Pharmaceuticals Announces First RNAi Drug Candidate Having a Novel, Proprietary Structure Covered by Quark Intellectual Property
10. Quark Pharmaceuticals Announces Publication of Study on Use of siRNA against Proprietary Target for Inhibiting Tumor Growth and Sensitization of Cancer Cells to Chemotherapy
11. Quark Pharmaceuticals Announces Dosing of the First Patient in Phase I/II Clinical Trial for Systemically Delivered siRNA Drug Candidate for Delayed Graft Function
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... YORK , May 27, 2015 Protein ... source, based on differences in their physical properties. The ... the largest amount of functional protein with fewest contaminants. ... to grow at a CAGR of around 5% to ... driven by increased research in the pharmaceutical and biotechnological ...
(Date:5/27/2015)... May 27, 2015 ... has announced the addition of the  "2015 ... Market"  report to their offering. ... issues pertaining to the US NAT laboratory ... demographic, social and technological trends with significant ...
(Date:5/27/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/s9qx9j/asia_pacific_open ) ... Open System MRI Market - Growth, Trends And ... offering.       (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , , ... the fastest growing market for Open System MRI. ... replacing CT because of its higher sensitivity and ...
Breaking Medicine Technology:Protein Purification & Isolation Market by Technology by Product by Application & End User - Global Forecast to 2020 2Protein Purification & Isolation Market by Technology by Product by Application & End User - Global Forecast to 2020 3United States Nucleic Acid Testing Market Strategies 2015-2020 2Asia Pacific Open System MRI Market Trends and Forecasts 2015-2019 2
... and AMSTERDAM, August 10, 2011 Agendia, ... the 12th St. Gallen International Breast Cancer Conference (2011) ... - classifying patients by the particular biological subtype of ... cancer patients. According to the panel, "it is no ...
... is unpredictable and can be even more so when you ... sneezing or itchy, watery eyes just might earn you top ... Facebook.  Allergy sufferers are invited to upload a short video ... win $5,000 toward a fun-filled adventure where they can enjoy ...
Cached Medicine Technology:International St. Gallen Expert Panel Highlights Importance of Molecular Subtyping in Breast Cancer Treatment 2International St. Gallen Expert Panel Highlights Importance of Molecular Subtyping in Breast Cancer Treatment 3Allegra® and Survivor Winner Danni Boatwright Want to Hear About Your "Allergy Adventures" 2Allegra® and Survivor Winner Danni Boatwright Want to Hear About Your "Allergy Adventures" 3Allegra® and Survivor Winner Danni Boatwright Want to Hear About Your "Allergy Adventures" 4
(Date:5/27/2015)... the first to come out with a non-surgical skin-tightening device. ... release of NXT or CPT, the second-generation of the device ... practice in New York to debut the new platform by ... been achieved before non-surgically. Even today, almost 15 years ... the leading skin tightening device. The FDA cleared ...
(Date:5/27/2015)... 27, 2015 StatRad, a leading provider ... pleased to introduce Mr. Chris E. Hafey as its ... proven track record of leading new development projects and ... He most recently served as the Chief Technology Officer ... of Chief Architect for Vital Images. , "I am ...
(Date:5/27/2015)... Pasadena, California (PRWEB) May 27, 2015 ... were marked by a few historic firsts -- and ... at the Pasadena Civic Center marked the first time ... and the first time a Graduate College of Biomedical ... Medicine of the Pacific (COMP). , The university’s fifth ...
(Date:5/27/2015)... (PRWEB) May 27, 2015 Ticket Down is a ... The Cavs have been super hot during the 2014-15 NBA ... by 30 points with a final score of 118-88. ... NBA Finals since 2006-2007 when they lost to the San ... summer, the chances of the Cavaliers making it to the NBA ...
(Date:5/27/2015)... 2015 The BBB Code of Business ... that enhance customer trust and confidence in business. The ... eight principles that summarize important elements of creating and ... for business accreditation by BBB. Businesses based in the ... complete application procedures will be accredited by BBB. , ...
Breaking Medicine News(10 mins):Health News:Non-Surgical Fat Reduction and Skin Tightening Procedures, Thermage and Exilis, Increase 200% at Precision Aesthetics in New York, April 2015 2Health News:StatRad Introduces Mr. Chris E. Hafey as Chief Technology Officer, and the Release of its Advanced Pure HTML5 DICOM Image Uploader 2Health News:WesternU Commencement Celebrates Achievements of Graduates and Founding President 2Health News:WesternU Commencement Celebrates Achievements of Graduates and Founding President 3Health News:WesternU Commencement Celebrates Achievements of Graduates and Founding President 4Health News:WesternU Commencement Celebrates Achievements of Graduates and Founding President 5Health News:Cavs NBA Finals Tickets: Ticket Down Slashes Ticket Prices on Cleveland Cavaliers 2015 NBA Finals Tickets at Quicken Loans Arena and Offers Valuable Promo Code 2Health News:Carson Energy Receives A+ Accredited Rating For 19 Consecutive Years 2
... chemistry graduates remains reasonably good and similar to what ... jobs remain less plentiful than they were for graduates ... the American Chemical Society (ACS). , The median salary ... less than a year of technical work before graduation ...
... avenues of treatment for the disorder, study suggests , , MONDAY, ... (ASD) may show improvements in behavior when they have a ... first study to investigate a relationship between fever and behavior ... said. , "I think this study means there is ...
... suffering from body dysmorphic disorder (BDD) perceive themselves as ... the brains of people with BDD look normal, but ... the December edition of the Archives of General Psychiatry, ... biological reason for patients distorted body image. ...
... SEATTLE People who undergo nonmyeloablative stem-cell transplants, ... blood cancers have comparable outcomes regardless of whether ... or unrelated donor, according to new findings by ... research by Marco Mielcarek, M.D., and colleagues in ...
... quarter to one third of adult men and women ... disease, and other serious illnesses. Patients have long been ... restriction has been found to be more effective at ... the syndrome. Now, a new study indicates that a ...
... Inc. (Nasdaq:,CEPH) today announced that the U.S. Food ... review designation to the TREANDA(R),(bendamustine HCl) New Drug ... chronic lymphocytic leukemia (CLL). CLL is a slowly,progressing ... 15,000 new,cases diagnosed every year in the United ...
Cached Medicine News:Health News:Fever May Improve Behavior of Children With Autism Disorders 2Health News:Fever May Improve Behavior of Children With Autism Disorders 3Health News:Distorted self-image due to visual brain glitch, UCLA research finds 2Health News:Distorted self-image due to visual brain glitch, UCLA research finds 3Health News:'Mini transplant' patients' outcomes similar using related and unrelated donor cells 2Health News:Low-carb diet reduces inflammation and blood saturated fat in metabolic syndrome 2Health News:TREANDA New Drug Application for the Treatment of Chronic Lymphocytic Leukemia Granted Priority Review Status by FDA 2Health News:TREANDA New Drug Application for the Treatment of Chronic Lymphocytic Leukemia Granted Priority Review Status by FDA 3Health News:TREANDA New Drug Application for the Treatment of Chronic Lymphocytic Leukemia Granted Priority Review Status by FDA 4Health News:TREANDA New Drug Application for the Treatment of Chronic Lymphocytic Leukemia Granted Priority Review Status by FDA 5
Lab-Incubator/Shaker....
... Timer are designed to give reliable performance for ... The on/off button, power supply socket and fuse ... the unit. The speed knob is located on ... speed from a minimum 950 rpm to a ...
... is a unique microprocessor controlled shaking incubator ... either 96 or 384 well format. Speed, ... control panel and all are displayed on ... the clear protective cover. The Millennium 2000 ...
Microplate incubator shaker used in a variety of immunoassay and research procedures requiring microplates....
Medicine Products: